3rd Quarter - Report

ALLIANCE FOR AGING RESEARCH for ALLIANCE FOR AGING RESEARCH

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Meeting with Senate Finance Committee staff to discuss recommendations for xx Signed letter asking requesting that all health education materials related to COVID-19 be accessible in at least 19 written languages and American Sign Language, support for interpretation services at COVID-19 testing sites, and to make comprehensive data available through the collection of regular reporting of language and disability characteristic of COVID-19 cases The Alliance for Aging Research publicly supported S.Res.655 - A resolution declaring racism a public health crisis. Signed a letter to House Telehealth Caucus in support of Protecting Access to Post-COVID-19 Telehealth Act of 2020 (HR 7663). Signed a letter requesting $10 million for the Administration on Community Living and $4 million for the Centers for Disease Control and Prevention to increase support for falls prevention. Had a meeting with Senate Finance staff to discuss the Committee's priorities to improve the treatment and care coordination for Alzheimer's disease patients after its hearing entitled "Alzheimers Awareness: Barriers to Diagnosis, Treatment, and Care Coordination" Signed letter requesting Congress address the need to expand access to COVID-19 and influenza testing and immunization by designating pharmacists as providers under Medicare Part B.

LobbyistCovered position, as disclosed
RYNE C. CARNEY Intern Rep. Ed Perlmutter
MICHAEL WARD New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS)

Bills named: H.R. 7663 (116th), S.Res. 655 (116th)

Postal POS

Signed a Leadership Council for Aging Organizations letter requesting Congress to provide additional resources to support the U.S. Postal Service before November 3, 2020

LobbyistCovered position, as disclosed
RYNE C. CARNEY —
MICHAEL WARD —

Contacted: SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Had meetings with HHS and CMS to discuss the proposed national coverage decision (NCD) memo for mitral valve Transcatheter Edge-to-Edge Repair (TEER) Signed a letter to the Center for Clinical Standards and Quality proposing principles around the coverage of beta amyloid PET scans. Submitted a sign on letter to Congressional leadership in support of an annual out-of-pocket cap in Medicare Part D, a mechanism to smooth patients OOP costs over a plan year, and a commitment that Part D reforms not include international reference pricing in coverage or reimbursement decision-making. Signed a letter on the Establishing Minimum Standards in Medicaid State Drug Utilization Review (DUR) and Supporting Value-Based Purchasing (VBP) for Drugs Covered in Medicaid, Revising Medicaid Drug Rebate and Third-Party Liability (TPL) Requirements (CMS 2482-P). The letter expressed concern over a provision that would increase barriers to access of care that would require drug manufactures to include the value of cost-sharing assistance when calculating best price. Submitted a letter to the Department of Health and Human Services and the Centers for Medicare and Medicaid Services on the proposed national coverage decision (NCD) memo for mitral valve Transcatheter Edge-to-Edge Repair (TEER) Had meetings with the Centers for Medicare and Medicaid Services to discuss the appropriate use of psychoactive medication in long-term care facilities.

LobbyistCovered position, as disclosed
RYNE C. CARNEY Intern Rep. Ed Perlmutter
MICHAEL WARD New —

Contacted: Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS)

Medical/Disease Research/Clinical Labs MED

Call with the FDA to discuss public communications regarding COVID-19 vaccines The Alliance for Aging Research submitted a comment letter to the FDA regarding our priorities for the Reauthorization of the Drug User Fee Act (PDUFA). Signed an Ad Hoc Group for Medical Research letter requesting that a COVID-19 relief package include $15.5 billion for the National Institutes of Health (NIH) Signed a letter to the Department of Health and Human Services expressing concern for the NIH Human Fetal Tissue Ethics Advisory Board. The letter asked HHS to reject the Ethics Advisory Boards recommendations through 42 U.S. Code 289a-1(b).

LobbyistCovered position, as disclosed
RYNE C. CARNEY Intern. Rep. Ed Perlmutter
MICHAEL WARD —

Contacted: HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Budget/Appropriations BUD

Signed a Friends of AHRQ letter in support of the AHRQ Funding Bill, H.R. 8067

LobbyistCovered position, as disclosed
RYNE C. CARNEY Intern, Rep. Ed Perlmutter

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 8067 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.